Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
DVA DaVita Inc. daily Stock Chart
DVA [NYSE]
DaVita Inc.
Healthcare | Specialized Health Services | USA
statements
IndexS&P 500 P/E18.17 EPS (ttm)3.29 Insider Own0.40% Shs Outstand166.35M Perf Week-0.91%
Market Cap9.94B Forward P/E11.28 EPS next Y5.30 Insider Trans0.00% Shs Float156.67M Perf Month6.87%
Income547.50M PEG0.95 EPS next Q1.20 Inst Own97.20% Short Float9.39% Perf Quarter14.00%
Sales11.25B P/S0.88 EPS this Y4.20% Inst Trans0.69% Short Ratio4.55 Perf Half Y8.64%
Book/sh24.34 P/B2.45 EPS next Y13.03% ROA0.70% Target Price66.45 Perf Year-15.50%
Cash/sh21.53 P/C2.78 EPS next 5Y19.16% ROE3.50% 52W Range43.40 - 79.11 Perf YTD16.11%
Dividend- P/FCF8.84 EPS past 5Y4.40% ROI9.20% 52W High-24.47% Beta1.62
Dividend %- Quick Ratio1.10 Sales past 5Y-0.60% Gross Margin28.80% 52W Low37.67% ATR1.73
Employees77700 Current Ratio1.10 Sales Q/Q-1.50% Oper. Margin13.00% RSI (14)51.53 Volatility3.13% 2.84%
OptionableNo Debt/Eq2.21 EPS Q/Q2.60% Profit Margin1.20% Rel Volume1.56 Prev Close61.30
ShortableYes LT Debt/Eq1.33 EarningsAug 01 AMC Payout0.00% Avg Volume3.23M Price59.75
Recom2.40 SMA202.27% SMA502.38% SMA2008.42% Volume5,046,797 Change-2.53%
Sep-11-19Downgrade William Blair Outperform → Mkt Perform
Jul-26-19Downgrade Robert W. Baird Outperform → Neutral $70 → $65
Jan-08-19Upgrade UBS Sell → Neutral
Jan-03-19Initiated Deutsche Bank Buy $60
Dec-14-18Initiated Barclays Overweight
Nov-28-18Upgrade Raymond James Mkt Perform → Outperform
Nov-16-18Initiated UBS Sell $64
Nov-08-18Downgrade Raymond James Strong Buy → Mkt Perform
Sep-13-18Upgrade JP Morgan Underweight → Neutral
Jan-04-18Upgrade BofA/Merrill Neutral → Buy
Dec-12-17Upgrade Robert W. Baird Neutral → Outperform $63 → $82
Dec-11-17Upgrade Citigroup Neutral → Buy
Dec-07-17Upgrade Raymond James Outperform → Strong Buy
Nov-08-17Reiterated RBC Capital Mkts Sector Perform $64 → $60
Oct-09-17Downgrade JP Morgan Neutral → Underweight
Jun-26-17Downgrade Jefferies Buy → Hold
Dec-13-16Downgrade Robert W. Baird Outperform → Neutral $68 → $69
Sep-20-16Upgrade Raymond James Mkt Perform → Outperform
Sep-06-16Initiated Citigroup Neutral
Sep-06-16Downgrade BofA/Merrill Buy → Neutral
Sep-19-19 04:58PM  US Markets Green on Thursday GuruFocus.com
12:33PM  Jim Chanos unveils short position in kidney-dialysis firm DaVita MarketWatch
11:15AM  11 Most Aggressively Shorted Stocks Benzinga
Sep-18-19 09:20AM  5 Low Price-to-Book Stocks to Increase Your Portfolio's Value Zacks
Sep-17-19 11:21AM  Jim Cramer Gives His Opinion On Ulta Beauty, Davita And More Benzinga
Sep-16-19 09:30AM  DVA vs. AMED: Which Stock Should Value Investors Buy Now? Zacks
08:41AM  5 Buffett-Style Value Picks Boasting Impressive PEG Ratio Zacks
Sep-11-19 03:34PM  Wall Street Edges Higher Wednesday GuruFocus.com
09:30AM  Zacks.com featured highlights include: DaVita, Hibbett, First Horizon, Universal Forest and Popular Zacks
Sep-10-19 07:20AM  5 Stocks With Amazingly Low EV/EBITDA Ratios to Own Now Zacks
Sep-09-19 11:27AM  The Zacks Analyst Blog Highlights: Exantas, Chemed, Viad, Arbor Realty and DaVita Zacks
Sep-06-19 06:54PM  3 Predictable Stocks Warren Buffett and Ray Dalio Agree On GuruFocus.com
07:12AM  Strong ISM Services Index Eases Recession Fears: 5 Top Picks Zacks
Sep-05-19 08:05AM  5 Price-to-Book Value Picks for September Zacks
Sep-04-19 12:52PM  Wall Street Red in the 1st Trading Day of September GuruFocus.com
09:15AM  Stocks Slide to Start September Zacks
Aug-31-19 09:31AM  Why Is DaVita HealthCare (DVA) Down 5% Since Last Earnings Report? Zacks
Aug-29-19 04:10PM  Draghi Says Goodbye. Should You Care? Zacks
03:54PM  When to Buy Global Markets? Zacks
09:40AM  DVA vs. CHE: Which Stock Is the Better Value Option? Zacks
Aug-28-19 08:36AM  5 Stocks From the Best Performing Sectors in Q2 Zacks
Aug-27-19 06:35AM  DaVita Inc. Schedules Capital Markets Day for September 10, 2019 PR Newswire
Aug-26-19 12:12PM  Does DaVita (NYSE:DVA) Have A Healthy Balance Sheet? Simply Wall St.
Aug-22-19 04:24PM  Andreas Halvorsen Keeps Buying Centene, DaVita GuruFocus.com
06:30AM  Davita Announces Final Results Of Self-Tender Offer PR Newswire
Aug-21-19 09:12AM  DaVita buys back $1.2 billion worth of stock from shareholders American City Business Journals
Aug-20-19 11:55AM  RingCentral, Tapestry, JD.com, DaVita and Aercap highlighted as Zacks Bull and Bear of the Day Zacks
07:45AM  Here's Why You Should Invest in DaVita (DVA) Stock For Now Zacks
Aug-19-19 05:21PM  Wall Street Rallies Monday GuruFocus.com
09:35AM  Is DaVita (DVA) a Profitable Stock for Value Investors Now? Zacks
06:55AM  5 Price-to-Book Value Picks to Improve Portfolio Returns Zacks
06:30AM  DaVita Announces Preliminary Results Of Self-Tender Offer PR Newswire
Aug-16-19 04:09PM  Main Wall Street Indexes Extend Gains Friday GuruFocus.com
08:53AM  Outlook for Outpatient and Home Healthcare Industry Looks Bright Zacks
07:16AM  SSM Health partners with Denver firm to offer new primary care option American City Business Journals
Aug-14-19 08:51AM  The Zacks Analyst Blog Highlights: Alamos Gold, Chemed, Safehold, Franco-Nevada and DaVita Zacks
Aug-13-19 09:30AM  DVA or CHE: Which Is the Better Value Stock Right Now? Zacks
09:26AM  5 Safe Picks Amid Yield Inversion and Geopolitical Concerns Zacks
09:15AM  Better Than Last Monday, but Still Down Over 1% Zacks
Aug-12-19 11:46AM  DaVita Announces New Senior Secured Credit Agreement PR Newswire
Aug-08-19 11:55AM  Zacks.com featured highlights include: DaVita, Kraton, ADT, Universal Forest Products and International Game Zacks
10:20AM  Why DaVita HealthCare (DVA) Might be Well Poised for a Surge Zacks
Aug-07-19 10:45AM  The Zacks Analyst Blog Highlights: Industrial Logistics, Medpace, Unitil, DaVita and Telephone and Data Zacks
06:50AM  5 Value Picks Boasting Strikingly Low EV/EBITDA Ratios Zacks
03:34AM  Edited Transcript of DVA earnings conference call or presentation 1-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-06-19 09:20AM  Relative Price Strength Make These 5 Stocks Worth a Look Now Zacks
09:19AM  5 Stocks to Buy on a Possible Second Rate Cut in September Zacks
Aug-05-19 10:25AM  Stock Market News For Aug 5, 2019 Zacks
Aug-02-19 10:22AM  Stock Market News for Aug 02, 2019 Zacks
09:32AM  DaVita sees growth slowdown ahead of federal changes to kidney care American City Business Journals
08:22AM  DaVita (DVA) Earnings Beat, Revenues Miss Estimates in Q2 Zacks
03:24AM  DaVita (DVA) Q2 2019 Earnings Call Transcript Motley Fool
Aug-01-19 05:15PM  DaVita HealthCare (DVA) Q2 Earnings Top Estimates Zacks
04:01PM  DaVita Inc. 2nd Quarter 2019 Results PR Newswire
07:56AM  6 Promising Price-to-Book Value Stocks to Buy in August Zacks
07:36AM  Earnings Preview For DaVita Benzinga
Jul-31-19 09:05AM  Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings? Zacks
Jul-30-19 12:28PM  Innovation in Home Care Delivery Improves the Quality of Life for More Kidney Patients PR Newswire
09:15AM  All Mixed Up to Start Fed Week Zacks
09:14AM  At US$59.66, Is It Time To Put DaVita Inc. (NYSE:DVA) On Your Watch List? Simply Wall St.
08:56AM  Cigna (CI) to Report Q2 Earnings: What's in the Offing? Zacks
Jul-29-19 11:14AM  Is a Beat in the Cards for Humana's (HUM) Earnings in Q2? Zacks
10:04AM  What's in the Cards for DaVita (DVA) This Earnings Season? Zacks
09:25AM  DaVita talks plans for home dialysis growth in wake of federal order American City Business Journals
Jul-26-19 01:49PM  Reducing Blind Spots GuruFocus.com
10:11AM  Top Ranked Momentum Stocks to Buy for July 26th Zacks
Jul-25-19 10:33AM  DaVita HealthCare (DVA) Earnings Expected to Grow: Should You Buy? Zacks
09:30AM  DVA vs. CHE: Which Stock Is the Better Value Option? Zacks
Jul-23-19 11:54AM  US Stocks Climb Monday GuruFocus.com
09:39AM  Stock Market News For Jul 23, 2019 Zacks
08:48AM  DaVita (DVA) Announces Preliminary Q2 Results, View Upbeat Zacks
Jul-22-19 01:39PM  DaVita News: DVA Stock Soars on Upbeat Guidance InvestorPlace
01:02PM  DaVita Inc. -- Moody's assigns Ba1 rating to DaVita's new senior secured debt, affirms Ba2 CFR Moody's
11:30AM  DaVita Jumps After Dialysis-Clinic Operator Boosts 2019 Forecast Bloomberg
09:37AM  DaVita Stock Jumps Because Its Next Earnings Report Should Be a Good One Barrons.com
07:40AM  DaVita's stock rallies after profit outlook raised MarketWatch
06:30AM  DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock For An Aggregate Purchase Price Of No More Than $1.2 Billion At A Purchase Price Of Not Less Than $53.50 Per Share And Not More Than $61.50 Per Share PR Newswire
06:02AM  DaVita Soars on Upbeat Earnings Guidance TheStreet.com
05:00AM  DaVita Inc. Announces Preliminary Second Quarter 2019 Results and Updated Guidance for Fiscal Year 2019 PR Newswire
04:59AM  DaVita Inc. Schedules 2nd Quarter 2019 Investor Conference Call PR Newswire
Jul-18-19 08:51AM  UnitedHealth (UNH) Beats on Q2 Earnings, Guides Up for 2019 Zacks
Jul-17-19 06:52PM  Industry Knowledge: How Much Is Enough? GuruFocus.com
04:00PM  CVS Health Tests Home Dialysis System; DaVita, Fresenius Hit Investor's Business Daily
08:00AM  CVS enters home dialysis care with clinical trial of new system Reuters
Jul-16-19 07:14AM  UnitedHealth (UNH) to Report Q2 Earnings: What's in Store? Zacks
Jul-14-19 12:12PM  Blind Spots in Investing GuruFocus.com
Jul-12-19 12:08PM  Why Fresenius Is the Initial Winner From Trump's Kidney Disease Overhaul GuruFocus.com
10:28AM  The Zacks Analyst Blog Highlights: DaVita, Fresenius, Baxter, Amgen and CVS Zacks
07:00AM  Home Dialysis to Benefit These Undervalued Providers Morningstar
Jul-11-19 05:06PM  Dow Jones Passes 27,000 for the 1st Time GuruFocus.com
01:53PM  Humana, CVS, and DaVita Stocks Could Benefit From Trump Overhaul of Kidney Care, Analysts Say Barrons.com
09:20AM  Trump's Order on Kidney Care Lifts These Dialysis Stocks Zacks
08:50AM  3 Big Stock Charts for Thursday: Davita, Honeywell and Advanced Micro Devices InvestorPlace
Jul-10-19 05:53PM  US Market Indexes Higher on Wednesday GuruFocus.com
05:32PM  Trump's Kidney Disease Executive Order May Boost This Health Stock, Tank Others Zacks
04:58PM  Trump Calls for Overhaul of Costly Kidney Dialysis Program Bloomberg
03:01PM  DaVita Statement on Advancing American Kidney Health PR Newswire
02:13PM  How DaVita could be impacted by Trump's action on kidney health American City Business Journals
02:03PM  Trump celebrates dismissal of foreign-payments case as he directs kidney-care overhaul MarketWatch
01:26PM  DaVita, American Renal stocks bounce after President Trump signs executive order on kidney disease MarketWatch
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2018, it provided dialysis and administrative services in the United States through a network of 2,664 outpatient dialysis centers serving approximately 202,700 patients; and operated 241 outpatient dialysis centers located in 9 countries outside of the United States serving approximately 25,000 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
open in yahoo | open in reuters | open in google